Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT07252765
Recruiting Observational

Nutritional Management of the Patient With Type 2 Diabetes at Nutritional Risk or With Malnutrition in Clinical Practice

NCT07252765 · tracked via the Priya Life Science Spain tracker
Phase
Observational
Started
2025-11-20
Last updated
2026-01-28

Condition(s) studied

Type 2 Diabetes Mellitus (T2DM)MalnutritionMalnourishmentDrug-Induced Diabetes

Study summary

The objective of this observational study is to characterize the patient profile and nutritional treatment patterns of individuals with type 2 diabetes (T2D) or drug-induced diabetes who present with malnutrition, or are at risk of it, and who are prescribed a diabetes-specific oral nutritional supplement (ONS) that is high in calories and protein and contains soluble fiber.

Participants will complete a series of questionnaires during visits 1 and 3.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Adult patients diagnosed with type 2 diabetes (T2D) or drug-induced diabetes * Patients at nutritional risk according to MUST or presenting malnutrition according to GLIM criteria. * Patients requiring a diabetes-specific oral nutritional supplement (ONS) that is high-calorie, high-protein, and contains soluble fiber in real-world clinical practice, and who have been prescribed such a supplement within the previous 7 days. * Patients able to provide informed consent and complete the study questionnaires. Exclusion Criteria: * Patients participating in other studies or clinical trials related to malnutrition, or who, in the investigator's opinion, may alter the course of the study. * Patients currently receiving or expected to receive other types of nutritional interventions involving supplements (oral or otherwise) or non-conventional feeding methods (e.g., feeding tubes). * Patients with a history of metabolic/endocrine diseases (other than diabetes) or any other condition causing liver or kidney failure, defined as ALT \> 3x ULN or eGFR \< 30 ml/min/1.73 m², and according to the investigator's judgment. * Patients expected to undergo any surgical intervention or require hospitalization due to a condition unrelated to the study during the study period. * Patients with other conditions that, in the investigator's opinion, may interfere with adherence to the intervention or with study procedures.

Primary outcome measure(s)

Trial sites (12)

FacilityCityRegionStatus
Hospital Universitario Marqués de Valdecilla Santander Cantabria Recruiting
Hospital Universitario Juan Ramón Jiménez Huelva Huelva Recruiting
Hospital UniversitarioDoctor Negrín Las Palmas de Gran Canaria Las Palmas Recruiting
Hospital La Princesa Madrid Madrid Recruiting
Hospital Clínico San Carlos Madrid Madrid Recruiting
Hospital Universitario La Paz Madrid Madrid Recruiting
Hospital Virgen de la Victoria Málaga Malaga Recruiting
Hospital Universitario Central de Asturias Oviedo Principality of Asturias Recruiting
Hospital Universitario Virgen del Rocío Seville Sevilla Recruiting
Hospital Universitario Virgen de la Macarena Seville Sevilla Recruiting
Hospital La Fe Valencia Valencia Recruiting
Hospital General de Valencia Valencia Valencia Recruiting

More Outcomes'10 trials in Spain

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07252765 on ClinicalTrials.gov ↗ ← All trials in Spain